Si-bone, Inc. SIBN

What this company does

The company's products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. As of December 31, 2025, over 140,000 procedures had been performed using the company's products since it introduced iFuse in 2009. The company markets its products primarily with a direct sales force as well as a number of third-party sales agents in the United States, and with a combination of a direct sales force, sales agents and resellers in other countries. As of December 31, 2025, its international sales force consisted of 11 sales representatives directly employed by the company and 28 third-party sales agents, which together had sales in 38 countries through that date. As of December 31, 2025, the company had 376 employees, including sales and marketing, product development, general administrative and accounting, both domestically and internationally. SI-BONE was founded in 2008 by orthopedic surgeon Mark A. Reiley, M.D., its current Chairman of the Board Jeffrey W. Dunn, and orthopedic surgeon Leonard Rudolf, M.D., and the company was incorporated in Delaware in March 2008.

Written from the business description in SI-BONE, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 24 February 2026. Every sentence was checked against that document before publication.